- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma.
February 11, 2020
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.
February 11, 2020
NK Cell-Based Immunotherapy in Renal Cell Carcinoma.
February 11, 2020
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.
February 10, 2020
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma.
February 10, 2020
Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report.
February 7, 2020
SEOM clinical guideline for treatment of kidney cancer (2019).
February 7, 2020
Oncologic Outcomes in Young Adults With Kidney Cancer Treated During the Targeted Therapy Era.
February 6, 2020
The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma.
February 6, 2020
PD-L1 expression is an unfavourable prognostic indicator in Asian renal cell carcinomas.
February 5, 2020
Replisome genes regulation by anti-tumor miR-101-5p in clear cell renal cell carcinoma.
February 5, 2020
miR-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
February 5, 2020
Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
February 4, 2020
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
February 4, 2020